{
  "docId": "019de072-a06b-75fe-abfc-06d6c9b36d69",
  "docSlug": "20a8e4b0fa87449fed1951c46c728b45",
  "documentTitle": "argenx SE | Results Presentation Deck | 21 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 21,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide uses a line chart for longitudinal data and a stacked bar chart for categorical response rates.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a06b-75fe-abfc-06d6c9b36d69/9",
  "deckHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69",
  "deckJsonHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69.json",
  "deckAnchorHref": "/decks/019de072-a06b-75fe-abfc-06d6c9b36d69#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.65,
        "y": 0.25
      },
      "kind": "chart",
      "text": "International Workgroup (IWG) Criteria reflecting real-world treatment goals",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "059d8308-1b40-4560-b6f7-06c9c54a4d13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.55,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Clear Separation Between VYVGART and Placebo",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50e31608-a4ab-4388-81fb-066c32967aac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "IWG Response: ≥30 x 10⁹ /L platelets, 2x increase from baseline, absence of bleeding events for ≥2 consecutive visits; IWG Complete response: ≥ 100 x 10⁹ /L platelets, absence of bleeding for ≥2 consecutive visits",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19b3c643-e3be-4d5f-9103-7340bcecd683",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Per IWG criteria, 51% of VYVGART Patients Showed Real-World Relevant Platelet Count Improvement in Absence of Bleeding",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d590e69-6932-41b4-a7b1-e385b9f8fb31",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}